Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Edward Johnson
25 Nov 2025
Director
Buy indirect
27,532
$43.12
$1.19M
David Edward Johnson
30 May 2024
Director
Buy indirect
225,000
$20.76
$4.67M
David Edward Johnson
28 May 2024
Director
Buy indirect
200,000
$20.32
$4.06M
David Edward Johnson
21 Feb 2024
Director
Buy indirect
190,000
$20.70
$3.93M
David Edward Johnson
27 Nov 2023
Director
Buy indirect
120,409
$21.61
$2.60M
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 706
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,557,913
Sales filed before the plan box existed 101
History held since 6 Oct 2006